Clinical trial Recruiting at 1 site Interventional Ages 60 to 100

Spinal anesthesia with intrathecal morphine vs PENG block (with or without dexamethasone) for hip replacement

Official title: Comparison of the Efficacy and Safety of Three Regional Anesthesia Strategies in Patients Undergoing Elective Total Hip Arthroplasty: A Prospective, Randomized, Multicenter Clinical Trial

Run by Poznan University of Medical Sciences · NCT07584200 · Data updated 2026-11-12

In people aged 60 and older undergoing total hip arthroplasty, this study tests whether three anesthesia approaches provide better pain control and fewer side effects: spinal with intrathecal morphine, spinal with a PENG block, or spinal with a PENG block plus dexamethasone.

Quick facts

Study typeInterventional
Ages60 Years to 100 Years
SexAll
Enrollment90 (estimated)
SponsorPoznan University of Medical Sciences
Academic / other
Locations1 site (Poznan)
StatusRecruiting
StartedMay 7, 2026
Main results expectedMarch 31, 2027
Study endsMay 1, 2027
Registry record updatedNovember 5, 2026
Trial IDNCT07584200 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 60 to 100 years scheduled for elective total hip arthroplasty with ASA I-III status who can give informed consent.

Probably not a fit

Patients who may not experience additional benefit include those who respond similarly to all three approaches or who have contraindications to regional anesthesia or dexamethasone.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter randomized trial compares three regional anesthesia strategies used with spinal anesthesia for elective hip replacement in adults 60 and older. Participants are assigned 1:1:1 to receive spinal anesthesia with intrathecal morphine, a spinal plus PENG block, or a spinal plus PENG block with dexamethasone. All groups use ropivacaine for the spinal component, and intrathecal morphine is used in the control group as part of routine care. The study aims to evaluate postoperative pain, opioid requirements, side effects, and recovery.

Why it matters

Potential benefit: If successful, the trial could identify an anesthesia approach that provides better pain control with fewer opioid needs and smoother recovery after hip replacement.

How similar studies have gone: Regional nerve blocks like PENG have shown promise as opioid-sparing strategies in orthopedic surgery, but this direct comparison with intrathecal morphine in hip arthroplasty is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 60 to 100 years
* Scheduled for elective total hip arthroplasty
* American Society of Anesthesiologists (ASA) physical status I-III
* Ability to understand the study procedures and provide written informed consent

Exclusion Criteria:

* Known allergy or hypersensitivity to ropivacaine, morphine, or dexamethasone
* Coagulation disorders or ongoing anticoagulant therapy contraindicating spinal anesthesia or regional nerve blocks
* Infection at the site of spinal or peripheral nerve block injection
* Pre-existing neurological disorders affecting sensory or motor function
* Severe hepatic or renal insufficiency
* Chronic opioid use for more than 3 months prior to surgery
* Refusal or inability to provide informed consent

Where it's running

  • Poznan University of Medical Sciences
    Poznan, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.